Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

European Vitreoretinal Update 2013. Abstracts of the Main Sessions,13th Euretina Congress, Hamburg, 2013

European Vitreoretinal Update 2013. Abstracts of the Main Sessions,13th Euretina Congress,... Abstracts Ophthalmologica Published online: September 26, 2013 Ophthalmologica 2013;230(suppl 1):1–30 DOI: 10.1159/000354999 Main Session 1: Ocular Tumors Conclusion: Intraveinous chemotherapy associated to local ophthalmological treatments is efficient in the con- servative management of most retinoblastomas. The number of drugs and number of cycle should be adapted according to the severity of the disease. Adding local che- Retinoblastoma motherapy can increase the rate of ocular preservation. L. Desjardins, L. Lumbroso LeRouic, C. Levy, N. Cassoux, R. Dendale, X. Sastre, A. Savignoni, I. Aerts, F. Doz Surgical Management of Uveal Melanoma Patients and Method: Treatment protocols applied since 1995 included intraveinous chemotherapy at vari- Nikolaos E. Bechrakis ous dosages with local ophthalmological treatment by Department of Ophthalmology, Innsbruck Medical University, Innsbruck, Austria transpupillary thermotherapy, cryotherapy and iodine 125 plaque brachytherapy. The data concerning initial findings, treatments used, and results are registered in The majority of uveal melanomas is treated by irradia- our database in a prospective way. We performed a retro- tion using various modalities such as brachytherapy or spective study of children treated between January 1995 teletherapy. The treatment of large uveal melanomas in and December 2009. particular poses a special therapeutic challenge due to the Results: There were 317 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Ophthalmologica Karger

European Vitreoretinal Update 2013. Abstracts of the Main Sessions,13th Euretina Congress, Hamburg, 2013

Ophthalmologica , Volume 230 (Suppl 1): 30 – Jan 1, 2013

Loading next page...
 
/lp/karger/european-vitreoretinal-update-2013-abstracts-of-the-main-sessions-13th-eVB1sba5xe

References (97)

Publisher
Karger
Copyright
© 2013 S. Karger AG, Basel
ISSN
0030-3755
eISSN
1423-0267
DOI
10.1159/000354999
Publisher site
See Article on Publisher Site

Abstract

Abstracts Ophthalmologica Published online: September 26, 2013 Ophthalmologica 2013;230(suppl 1):1–30 DOI: 10.1159/000354999 Main Session 1: Ocular Tumors Conclusion: Intraveinous chemotherapy associated to local ophthalmological treatments is efficient in the con- servative management of most retinoblastomas. The number of drugs and number of cycle should be adapted according to the severity of the disease. Adding local che- Retinoblastoma motherapy can increase the rate of ocular preservation. L. Desjardins, L. Lumbroso LeRouic, C. Levy, N. Cassoux, R. Dendale, X. Sastre, A. Savignoni, I. Aerts, F. Doz Surgical Management of Uveal Melanoma Patients and Method: Treatment protocols applied since 1995 included intraveinous chemotherapy at vari- Nikolaos E. Bechrakis ous dosages with local ophthalmological treatment by Department of Ophthalmology, Innsbruck Medical University, Innsbruck, Austria transpupillary thermotherapy, cryotherapy and iodine 125 plaque brachytherapy. The data concerning initial findings, treatments used, and results are registered in The majority of uveal melanomas is treated by irradia- our database in a prospective way. We performed a retro- tion using various modalities such as brachytherapy or spective study of children treated between January 1995 teletherapy. The treatment of large uveal melanomas in and December 2009. particular poses a special therapeutic challenge due to the Results: There were 317

Journal

OphthalmologicaKarger

Published: Jan 1, 2013

There are no references for this article.